Cognitive Behavioral Therapy for Gastroparesis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how Cognitive Behavioral Therapy (CBT), a type of talk therapy, can assist people with gastroparesis, a condition that slows or stops food movement through the stomach. Researchers aim to determine if CBT can alleviate symptoms like nausea and fullness, as well as related issues such as pain and anxiety. They will also analyze brain scans and other tests before and after therapy to understand its effects. Individuals who have experienced gastroparesis symptoms for at least 12 weeks and have internet access might be suitable for this trial. As an unphased trial, this study offers a unique opportunity to contribute to understanding how CBT can enhance life for those with gastroparesis.
Will I have to stop taking my current medications?
You can continue taking your current medications if they have been stable for at least 30 days before the study and you agree not to change them during the study. However, you cannot take psychotropic drugs, opioids, or illicit drugs.
What prior data suggests that Cognitive Behavioral Therapy is safe for treating gastroparesis?
Research has shown that Cognitive Behavioral Therapy (CBT) safely treats mental health issues. CBT helps individuals identify and change negative thought patterns. Studies have found it to be well-tolerated with minimal side effects. Most participants report a positive experience with CBT. By focusing on improving mental health without medication, it reduces the risk of adverse reactions. Overall, CBT is considered a safe choice for many.12345
Why are researchers excited about this trial?
Unlike the standard treatments for gastroparesis, which often involve medications to manage symptoms like nausea or dietary changes, Cognitive Behavioral Therapy (CBT) offers a unique approach by addressing the mental and emotional aspects of the condition. Researchers are excited about CBT because it uses a psychological method to potentially improve patients' quality of life through virtual sessions, making it more accessible and convenient. This therapy focuses on changing thought patterns related to the condition, which could lead to better management of symptoms without relying solely on medication.
What evidence suggests that Cognitive Behavioral Therapy is effective for gastroparesis?
Research has shown that Cognitive Behavioral Therapy (CBT), which participants in this trial will receive, can alleviate symptoms of gastroparesis. Studies have found that CBT reduces stomach-related symptoms and improves mental health by lowering depression and anxiety. One small study reported a significant decrease in the severity of gastroparesis symptoms and an enhanced overall quality of life. These findings suggest that CBT might be a useful non-drug option for managing gastroparesis and its related issues.678910
Who Is on the Research Team?
Braden Kuo, MD
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
This trial is for adults aged 18-65 with gastroparesis, a condition causing delayed stomach emptying. Participants must have had symptoms for at least 12 weeks and not received CBT for chronic illness before. They need internet access, speak English, be on stable medication doses, and have specific BMI and gastric emptying study results. Exclusions include MRI contraindications like metal implants or claustrophobia, certain medications use, other conditions that could cause similar symptoms or inability to comply with the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo an 8-week Cognitive Behavioral Therapy (CBT) trial with weekly sessions conducted via online videoconferencing
Post-Treatment Testing
Participants undergo post-treatment testing including brain MRI, autonomic function test (AFT), and nutrient drink test (NDT) to assess the impact of CBT
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments up to 12 weeks post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Behavioral Therapy
Cognitive Behavioral Therapy is already approved in European Union, United States, Canada for the following indications:
- Anxiety disorders
- Depressive disorders
- Eating disorders
- Post-traumatic stress disorder (PTSD)
- Obsessive-compulsive disorder (OCD)
- Anxiety disorders
- Depressive disorders
- Eating disorders
- Post-traumatic stress disorder (PTSD)
- Obsessive-compulsive disorder (OCD)
- Substance use disorders
- Anxiety disorders
- Depressive disorders
- Eating disorders
- Post-traumatic stress disorder (PTSD)
- Obsessive-compulsive disorder (OCD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor